BNT141
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BNT141, covering 2024-10-02 to 2024-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors [Phase 1, Phase 2]